CSP # - 526, A Thyroid Hormone Analog to Fight Heart Failure: Phase II Trial (DITPA)
Phase of Trial: Phase II
Latest Information Update: 07 Aug 2018
At a glance
- Drugs DITPA (Primary)
- Indications Heart failure
- Focus Pharmacodynamics; Therapeutic Use
- 25 Jan 2010 Results on DITPA effects on body weight, lipoproteins and bone metabolism markers were presented in the Journal of Clinical Endocrinology and Metabolism.
- 24 Apr 2008 Status changed from recruiting to terminated, as reported in ClinicalTrials.gov.
- 19 Oct 2005 New trial record.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History